What is the prevalence of Brugada Syndrome?

Brugada Syndrome is a rare genetic cardiac disorder with an estimated global prevalence of 1 in 2,000 to 1 in 5,000 individuals, though these figures vary significantly by region and ethnicity. Because many cases remain asymptomatic and undiagnosed, the true prevalence is likely higher than current clinical data suggests.

What is the estimated prevalence and incidence of Brugada Syndrome?

Determining the exact prevalence of Brugada Syndrome is challenging because the condition is often asymptomatic, leading to significant underdiagnosis. According to Orphanet and the NIH Genetic and Rare Diseases (GARD) Information Center, the estimated prevalence ranges from 1 in 2,000 to 1 in 5,000 people globally. Incidence—the number of new cases diagnosed each year—is difficult to calculate precisely, as many individuals are only identified after a sudden cardiac event or during routine screening for family members. Within the DiseaseMaps.org platform, 228 individuals have joined our community, providing a vital real-world perspective on the patient experience that often predates formal medical documentation.

How does Brugada Syndrome affect different populations?

Brugada Syndrome demonstrates distinct patterns regarding gender and ethnicity:

• Gender Distribution: The condition is significantly more common in males than females, with clinical studies suggesting that males are 8 to 10 times more likely to exhibit the characteristic electrocardiogram (ECG) patterns associated with Brugada Syndrome.


• Age of Onset: While Brugada Syndrome can be diagnosed at any age, the most common age of onset for life-threatening arrhythmias is during adulthood, typically between the ages of 30 and 50.


• Geographic and Ethnic Variations: There is a well-documented higher prevalence in Southeast Asian populations, particularly in Japan and Thailand, where the syndrome is a known cause of sudden unexplained nocturnal death syndrome (SUNDS).

Why is accurate data on Brugada Syndrome difficult to obtain?

The primary challenge in mapping Brugada Syndrome is its "dynamic" nature. The characteristic ECG pattern—the primary diagnostic tool—can fluctuate over time, appearing normal on one day and diagnostic on another. Many people live their entire lives without experiencing symptoms, meaning they never seek medical attention and are never recorded in clinical databases. Furthermore, misdiagnosis remains a hurdle; Brugada Syndrome can sometimes be mistaken for other arrhythmias or structural heart conditions, leading to an underreporting of true case numbers.

Is Brugada Syndrome considered a rare disease?

Yes, Brugada Syndrome is classified as a rare disease. Because it affects fewer than 1 in 2,000 people in many Western populations, it meets the criteria for "rare" or "orphan" disease status in many jurisdictions. However, its prevalence is notably higher in specific regions, which sometimes complicates international health policy and research funding. As our understanding of the SCN5A gene and other genetic markers improves, we expect to identify more sub-clinical cases, which may eventually lead to a revision of these prevalence estimates.

Next steps

• Consult a cardiac electrophysiologist if you have a family history of sudden cardiac death or unexplained fainting.


• Request a specialized ECG if your physician suspects Brugada Syndrome, as specific lead placements are often required for accurate detection.


• Join the DiseaseMaps.org community to connect with 228 other members who share lived experiences and coping strategies.


• Discuss genetic counseling with a specialist to understand potential risks for other family members.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• Orphanet: Brugada Syndrome (ORPHA:132).


• NIH Genetic and Rare Diseases (GARD) Information Center: Brugada Syndrome.


• OMIM (Online Mendelian Inheritance in Man): Brugada Syndrome 1 (Entry #601144).


• Heart Rhythm Society: Expert Consensus Statement on the Management of Arrhythmias.